XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
1.100
-0.060 (-5.17%)
At close: Jun 6, 2025, 4:00 PM
1.060
-0.040 (-3.64%)
After-hours: Jun 6, 2025, 4:00 PM EDT
XTL Biopharmaceuticals Market Cap
XTL Biopharmaceuticals has a market cap or net worth of $10.10 million as of June 6, 2025. Its market cap has decreased by -27.01% in one year.
Market Cap
10.10M
Enterprise Value
9.06M
1-Year Change
-27.01%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since August 31, 2005, XTL Biopharmaceuticals's market cap has decreased from $179.98M to $10.10M, a decrease of -94.39%. That is a compound annual growth rate of -13.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 674.00B |
| Johnson & Johnson | 371.55B |
| AbbVie | 330.76B |
| Novo Nordisk | 315.80B |
| UnitedHealth Group | 273.25B |
| Abbott Laboratories | 232.63B |
| Novartis AG | 226.74B |
| AstraZeneca | 223.00B |